As of 2025-05-14, the Relative Valuation of Deciphera Pharmaceuticals Inc (DCPH) is (44.92) USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.59 USD, the upside of Deciphera Pharmaceuticals Inc based on Relative Valuation is -275.5%.
The range of the Relative Valuation is (37.96) - (49.23) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.9x - 22.4x | 19.2x |
| Forward P/E multiples | 17.2x - 26.1x | 21.6x |
| Fair Price | (37.96) - (49.23) | (44.92) |
| Upside | -248.3% - -292.4% | -275.5% |
| Date | P/E |